APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Contrast Agent

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Contrast Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchOral Contrast Agent Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Contrast Agent Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oral Contrast Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Contrast Agent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Contrast Agent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral Contrast Agent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Contrast Agent include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Contrast Agent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Contrast Agent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Contrast Agent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Contrast Agent market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Contrast Agent Segment by Company

Daiichi Sankyo (Japan)

Bayer HealthCare (Germany)

Unijules Life Sciences (India)

Taejoon Pharm (South Korea)

Spago Nanomedicine (Sweden)

Magnus Health (India)

Lantheus (US)

Jodas (India)

J.B. Chemicals and Pharmaceuticals (India)

Guerbet (France)

GE Healthcare (US)

Bracco Imaging (Italy)

Oral Contrast Agent Segment by Type

Microbubble Contrast Media

Gadolinium-based Contrast Media

Iodinated Contrast Media

Barium-based Contrast Media

Oral Contrast Agent Segment by Application

Cardiovascular Disorders

Gastrointestinal Disorders

Nephrological Disorders

Neurological Disorders

Musculoskeletal Disorders

Cancer

Oral Contrast Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contrast Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Contrast Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contrast Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Contrast Agent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral Contrast Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral Contrast Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral Contrast Agent Industry Trends Table 2. Oral Contrast Agent Industry Drivers Table 3. Oral Contrast Agent Industry Opportunities and Challenges Table 4. Oral Contrast Agent Industry Restraints Table 5. Global Oral Contrast Agent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral Contrast Agent Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral Contrast Agent Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oral Contrast Agent Sales Market Share by Manufacturers Table 9. Global Oral Contrast Agent Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oral Contrast Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral Contrast Agent Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral Contrast Agent Manufacturers, Product Type & Application Table 13. Global Oral Contrast Agent Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Contrast Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Microbubble Contrast Media Table 17. Major Manufacturers of Gadolinium-based Contrast Media Table 18. Major Manufacturers of Iodinated Contrast Media Table 19. Major Manufacturers of Barium-based Contrast Media Table 20. Global Oral Contrast Agent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 22. Global Oral Contrast Agent Sales by Type (2027-2032) & (K Units) Table 23. Global Oral Contrast Agent Sales Market Share by Type (2021-2026) Table 24. Global Oral Contrast Agent Sales Market Share by Type (2027-2032) Table 25. Global Oral Contrast Agent Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Oral Contrast Agent Revenue by Type (2021-2026) & (K Units) Table 27. Global Oral Contrast Agent Revenue by Type (2027-2032) & (K Units) Table 28. Global Oral Contrast Agent Revenue Market Share by Type (2021-2026) Table 29. Global Oral Contrast Agent Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Cardiovascular Disorders Table 31. Major Manufacturers of Gastrointestinal Disorders Table 32. Major Manufacturers of Nephrological Disorders Table 33. Major Manufacturers of Neurological Disorders Table 34. Major Manufacturers of Musculoskeletal Disorders Table 35. Major Manufacturers of Cancer Table 36. Global Oral Contrast Agent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 38. Global Oral Contrast Agent Sales by Application (2027-2032) & (K Units) Table 39. Global Oral Contrast Agent Sales Market Share by Application (2021-2026) Table 40. Global Oral Contrast Agent Sales Market Share by Application (2027-2032) Table 41. Global Oral Contrast Agent Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Oral Contrast Agent Revenue by Application (2021-2026) & (K Units) Table 43. Global Oral Contrast Agent Revenue by Application (2027-2032) & (K Units) Table 44. Global Oral Contrast Agent Revenue Market Share by Application (2021-2026) Table 45. Global Oral Contrast Agent Revenue Market Share by Application (2027-2032) Table 46. Global Oral Contrast Agent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Oral Contrast Agent Sales by Region (2021-2026) & (K Units) Table 48. Global Oral Contrast Agent Sales Market Share by Region (2021-2026) Table 49. Global Oral Contrast Agent Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Oral Contrast Agent Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Oral Contrast Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 53. North America Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 54. Europe Oral Contrast Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 56. Europe Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Oral Contrast Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Oral Contrast Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 63. Global Oral Contrast Agent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Oral Contrast Agent Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Oral Contrast Agent Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Oral Contrast Agent Revenue Market Share by Region (2021-2026) Table 67. Global Oral Contrast Agent Revenue Market Share by Region (2027-2032) Table 68. Daiichi Sankyo (Japan) Company Information Table 69. Daiichi Sankyo (Japan) Business Overview Table 70. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio Table 72. Daiichi Sankyo (Japan) Recent Development Table 73. Bayer HealthCare (Germany) Company Information Table 74. Bayer HealthCare (Germany) Business Overview Table 75. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio Table 77. Bayer HealthCare (Germany) Recent Development Table 78. Unijules Life Sciences (India) Company Information Table 79. Unijules Life Sciences (India) Business Overview Table 80. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio Table 82. Unijules Life Sciences (India) Recent Development Table 83. Taejoon Pharm (South Korea) Company Information Table 84. Taejoon Pharm (South Korea) Business Overview Table 85. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio Table 87. Taejoon Pharm (South Korea) Recent Development Table 88. Spago Nanomedicine (Sweden) Company Information Table 89. Spago Nanomedicine (Sweden) Business Overview Table 90. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio Table 92. Spago Nanomedicine (Sweden) Recent Development Table 93. Magnus Health (India) Company Information Table 94. Magnus Health (India) Business Overview Table 95. Magnus Health (India) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Magnus Health (India) Oral Contrast Agent Product Portfolio Table 97. Magnus Health (India) Recent Development Table 98. Lantheus (US) Company Information Table 99. Lantheus (US) Business Overview Table 100. Lantheus (US) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Lantheus (US) Oral Contrast Agent Product Portfolio Table 102. Lantheus (US) Recent Development Table 103. Jodas (India) Company Information Table 104. Jodas (India) Business Overview Table 105. Jodas (India) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Jodas (India) Oral Contrast Agent Product Portfolio Table 107. Jodas (India) Recent Development Table 108. J.B. Chemicals and Pharmaceuticals (India) Company Information Table 109. J.B. Chemicals and Pharmaceuticals (India) Business Overview Table 110. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio Table 112. J.B. Chemicals and Pharmaceuticals (India) Recent Development Table 113. Guerbet (France) Company Information Table 114. Guerbet (France) Business Overview Table 115. Guerbet (France) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Guerbet (France) Oral Contrast Agent Product Portfolio Table 117. Guerbet (France) Recent Development Table 118. GE Healthcare (US) Company Information Table 119. GE Healthcare (US) Business Overview Table 120. GE Healthcare (US) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. GE Healthcare (US) Oral Contrast Agent Product Portfolio Table 122. GE Healthcare (US) Recent Development Table 123. Bracco Imaging (Italy) Company Information Table 124. Bracco Imaging (Italy) Business Overview Table 125. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio Table 127. Bracco Imaging (Italy) Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Oral Contrast Agent Distributors List Table 131. Oral Contrast Agent Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Oral Contrast Agent Product Image Figure 2. Global Oral Contrast Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Contrast Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Contrast Agent Sales (2021-2032) & (K Units) Figure 5. Global Oral Contrast Agent Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oral Contrast Agent Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Microbubble Contrast Media Image Figure 9. Gadolinium-based Contrast Media Image Figure 10. Iodinated Contrast Media Image Figure 11. Barium-based Contrast Media Image Figure 12. Global Oral Contrast Agent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Oral Contrast Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Oral Contrast Agent Sales Market Share by Type (2021-2032) Figure 15. Global Oral Contrast Agent Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Oral Contrast Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Oral Contrast Agent Revenue Market Share by Type (2021-2032) Figure 18. Cardiovascular Disorders Image Figure 19. Gastrointestinal Disorders Image Figure 20. Nephrological Disorders Image Figure 21. Neurological Disorders Image Figure 22. Musculoskeletal Disorders Image Figure 23. Cancer Image Figure 24. Global Oral Contrast Agent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Oral Contrast Agent Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Oral Contrast Agent Sales Market Share by Application (2021-2032) Figure 27. Global Oral Contrast Agent Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Oral Contrast Agent Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Oral Contrast Agent Revenue Market Share by Application (2021-2032) Figure 30. North America Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Oral Contrast Agent Sales Market Share by Country (2021-2032) Figure 32. U.S. Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Oral Contrast Agent Sales Market Share by Country (2021-2032) Figure 37. Germany Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Oral Contrast Agent Sales Market Share by Country (2021-2032) Figure 44. China Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Oral Contrast Agent Sales Market Share by Country (2021-2032) Figure 52. Brazil Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Oral Contrast Agent Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Oral Contrast Agent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Oral Contrast Agent Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Figure 63. North America Oral Contrast Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Figure 65. Europe Oral Contrast Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Oral Contrast Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Oral Contrast Agent Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Oral Contrast Agent Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Oral Contrast Agent Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Oral Contrast Agent Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Microbubble Contrast Media
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Barium-based Contrast Media
Applications
  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Nephrological Disorders
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Cancer
Companies covered
  • Daiichi Sankyo (Japan)
  • Bayer HealthCare (Germany)
  • Unijules Life Sciences (India)
  • Taejoon Pharm (South Korea)
  • Spago Nanomedicine (Sweden)
  • Magnus Health (India)
  • Lantheus (US)
  • Jodas (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Guerbet (France)
  • GE Healthcare (US)
  • Bracco Imaging (Italy)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Contrast Agent Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Contrast Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral Contrast Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral Contrast Agent Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral Contrast Agent Market Dynamics
  1. 2.1 Oral Contrast Agent Industry Trends
  2. 2.2 Oral Contrast Agent Industry Drivers
  3. 2.3 Oral Contrast Agent Industry Opportunities and Challenges
  4. 2.4 Oral Contrast Agent Industry Restraints
3 Oral Contrast Agent Market by Manufacturers
  1. 3.1 Global Oral Contrast Agent Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral Contrast Agent Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral Contrast Agent Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral Contrast Agent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Contrast Agent Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral Contrast Agent Manufacturers, Product Type & Application
  7. 3.7 Global Oral Contrast Agent Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Contrast Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Contrast Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Contrast Agent Tier 1, Tier 2, and Tier 3
4 Oral Contrast Agent Market by Type
  1. 4.1 Oral Contrast Agent Type Introduction
  2. 4.1.1 Microbubble Contrast Media
  3. 4.1.2 Gadolinium-based Contrast Media
  4. 4.1.3 Iodinated Contrast Media
  5. 4.1.4 Barium-based Contrast Media
  6. 4.2 Global Oral Contrast Agent Sales by Type
  7. 4.2.1 Global Oral Contrast Agent Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Oral Contrast Agent Sales by Type (2021-2032)
  9. 4.2.3 Global Oral Contrast Agent Sales Market Share by Type (2021-2032)
  10. 4.3 Global Oral Contrast Agent Revenue by Type
  11. 4.3.1 Global Oral Contrast Agent Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Oral Contrast Agent Revenue by Type (2021-2032)
  13. 4.3.3 Global Oral Contrast Agent Revenue Market Share by Type (2021-2032)
5 Oral Contrast Agent Market by Application
  1. 5.1 Oral Contrast Agent Application Introduction
  2. 5.1.1 Cardiovascular Disorders
  3. 5.1.2 Gastrointestinal Disorders
  4. 5.1.3 Nephrological Disorders
  5. 5.1.4 Neurological Disorders
  6. 5.1.5 Musculoskeletal Disorders
  7. 5.1.6 Cancer
  8. 5.2 Global Oral Contrast Agent Sales by Application
  9. 5.2.1 Global Oral Contrast Agent Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Oral Contrast Agent Sales by Application (2021-2032)
  11. 5.2.3 Global Oral Contrast Agent Sales Market Share by Application (2021-2032)
  12. 5.3 Global Oral Contrast Agent Revenue by Application
  13. 5.3.1 Global Oral Contrast Agent Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Oral Contrast Agent Revenue by Application (2021-2032)
  15. 5.3.3 Global Oral Contrast Agent Revenue Market Share by Application (2021-2032)
6 Global Oral Contrast Agent Sales by Region
  1. 6.1 Global Oral Contrast Agent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Contrast Agent Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Contrast Agent Sales by Region (2021-2026)
  4. 6.2.2 Global Oral Contrast Agent Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Contrast Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral Contrast Agent Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral Contrast Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral Contrast Agent Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral Contrast Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral Contrast Agent Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral Contrast Agent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral Contrast Agent Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral Contrast Agent Revenue by Region
  1. 7.1 Global Oral Contrast Agent Revenue by Region
  2. 7.1.1 Global Oral Contrast Agent Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral Contrast Agent Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral Contrast Agent Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral Contrast Agent Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral Contrast Agent Revenue (2021-2032)
  8. 7.2.2 North America Oral Contrast Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral Contrast Agent Revenue (2021-2032)
  11. 7.3.2 Europe Oral Contrast Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral Contrast Agent Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral Contrast Agent Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral Contrast Agent Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral Contrast Agent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Daiichi Sankyo (Japan)
  2. 8.1.1 Daiichi Sankyo (Japan) Company Information
  3. 8.1.2 Daiichi Sankyo (Japan) Business Overview
  4. 8.1.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio
  6. 8.1.5 Daiichi Sankyo (Japan) Recent Developments
  7. 8.2 Bayer HealthCare (Germany)
  8. 8.2.1 Bayer HealthCare (Germany) Company Information
  9. 8.2.2 Bayer HealthCare (Germany) Business Overview
  10. 8.2.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio
  12. 8.2.5 Bayer HealthCare (Germany) Recent Developments
  13. 8.3 Unijules Life Sciences (India)
  14. 8.3.1 Unijules Life Sciences (India) Company Information
  15. 8.3.2 Unijules Life Sciences (India) Business Overview
  16. 8.3.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio
  18. 8.3.5 Unijules Life Sciences (India) Recent Developments
  19. 8.4 Taejoon Pharm (South Korea)
  20. 8.4.1 Taejoon Pharm (South Korea) Company Information
  21. 8.4.2 Taejoon Pharm (South Korea) Business Overview
  22. 8.4.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio
  24. 8.4.5 Taejoon Pharm (South Korea) Recent Developments
  25. 8.5 Spago Nanomedicine (Sweden)
  26. 8.5.1 Spago Nanomedicine (Sweden) Company Information
  27. 8.5.2 Spago Nanomedicine (Sweden) Business Overview
  28. 8.5.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio
  30. 8.5.5 Spago Nanomedicine (Sweden) Recent Developments
  31. 8.6 Magnus Health (India)
  32. 8.6.1 Magnus Health (India) Company Information
  33. 8.6.2 Magnus Health (India) Business Overview
  34. 8.6.3 Magnus Health (India) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Magnus Health (India) Oral Contrast Agent Product Portfolio
  36. 8.6.5 Magnus Health (India) Recent Developments
  37. 8.7 Lantheus (US)
  38. 8.7.1 Lantheus (US) Company Information
  39. 8.7.2 Lantheus (US) Business Overview
  40. 8.7.3 Lantheus (US) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lantheus (US) Oral Contrast Agent Product Portfolio
  42. 8.7.5 Lantheus (US) Recent Developments
  43. 8.8 Jodas (India)
  44. 8.8.1 Jodas (India) Company Information
  45. 8.8.2 Jodas (India) Business Overview
  46. 8.8.3 Jodas (India) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jodas (India) Oral Contrast Agent Product Portfolio
  48. 8.8.5 Jodas (India) Recent Developments
  49. 8.9 J.B. Chemicals and Pharmaceuticals (India)
  50. 8.9.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
  51. 8.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
  52. 8.9.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio
  54. 8.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
  55. 8.10 Guerbet (France)
  56. 8.10.1 Guerbet (France) Company Information
  57. 8.10.2 Guerbet (France) Business Overview
  58. 8.10.3 Guerbet (France) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Guerbet (France) Oral Contrast Agent Product Portfolio
  60. 8.10.5 Guerbet (France) Recent Developments
  61. 8.11 GE Healthcare (US)
  62. 8.11.1 GE Healthcare (US) Company Information
  63. 8.11.2 GE Healthcare (US) Business Overview
  64. 8.11.3 GE Healthcare (US) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GE Healthcare (US) Oral Contrast Agent Product Portfolio
  66. 8.11.5 GE Healthcare (US) Recent Developments
  67. 8.12 Bracco Imaging (Italy)
  68. 8.12.1 Bracco Imaging (Italy) Company Information
  69. 8.12.2 Bracco Imaging (Italy) Business Overview
  70. 8.12.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio
  72. 8.12.5 Bracco Imaging (Italy) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Contrast Agent Value Chain Analysis
  2. 9.1.1 Oral Contrast Agent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Contrast Agent Production Mode & Process
  6. 9.2 Oral Contrast Agent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Contrast Agent Distributors
  9. 9.2.3 Oral Contrast Agent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst